ViewRay Announces China NMPA Approval of its MRIdian(R) MRI-Guided Radiation Therapy for Cancer Patients

This approval expands MRIdian's global reach and offers cancer patients a new radiation therapy option—MRIdian SMART DENVER, Sept. 7, 2022 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the company's MRId... Devices, Oncology, Regulatory ViewRay, MRIdian, MRI-guided radiation therapy, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news